Rare allelic imbalances, but no mutations of the PRDX1 gene in human hepatocellular carcinomas

J Clin Pathol. 2005 Nov;58(11):1229-31. doi: 10.1136/jcp.2004.024679.

Abstract

Allelic losses on chromosome 1p are frequent in hepatocellular carcinoma (HCC), suggesting the presence of a tumour suppressor gene in this region. The gene for peroxiredoxin 1 (PRDX1), an antioxidant enzyme, has been mapped to 1p34.1. Mice lacking PRDX1 develop HCC with high frequency. Because oxidative stress has been implicated in the pathogenesis of HCC, this study was designed to determine whether the PRDX1 gene is mutated in human HCC using loss of heterozygosity (LOH) analysis, polymerase chain reaction/denaturing gradient gel electrophoresis, and DNA sequencing. LOH of at least one of four microsatellite markers within 0.8 Mb of the PRDX1 gene was seen in three of 34 informative HCCs, but no mutations or polymorphisms in the translated exons 2-6 of the PRDX1 gene were found. These results suggest that genetic alterations of the PRDX1 locus are rare events in human HCC, indicating that other genes on chromosome 1p contribute to liver carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Allelic Imbalance*
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Chromosomes, Human, Pair 1 / genetics
  • Female
  • Heat-Shock Proteins / genetics*
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Loss of Heterozygosity
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm Proteins / genetics
  • Peroxidases / genetics*
  • Peroxiredoxins

Substances

  • Heat-Shock Proteins
  • Neoplasm Proteins
  • Peroxidases
  • PRDX1 protein, human
  • Peroxiredoxins